Showing 2071-2080 of 2735 results for "".
- AAD 2026: CO2 Laser Resurfacing Linked to Transient Microbiome Shiftshttps://modernaesthetics.com/news/aad-2026-co2-laser-resurfacing-linked-to-transient-microbiome-shifts/2486399/New findings presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, provide insight into dynamic microbiome changes following ablative CO2 laser resurfacing and their relationship to wound healing. In this monocentric, double-blind, rando
- AAD 2026: Survey Highlights Facial Concerns Among GLP-1 Weight Loss Patientshttps://modernaesthetics.com/news/aad-2026-survey-highlights-facial-concerns-among-glp-1-weight-loss-patients/2486397/A large survey presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, highlights evolving aesthetic concerns among patients receiving glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss. The analysis, based on responses from 406 US healthcare
- AAD 2026: Oral Supplement Shows Gains in Hair Strength, Collagen VIIhttps://modernaesthetics.com/news/aad-2026-oral-supplement-shows-gains-in-hair-strength-collagen-vii/2486396/New data presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, evaluated a nutraceutical approach to improving hair strength through collagen VII upregulation and mechanical resistance outcomes. The study assessed a daily oral supplement containing turmer
- FDA Clears Full-Wavelength Capability for Lasermach Laser Systemhttps://modernaesthetics.com/news/fda-clears-full-wavelength-capability-for-lasermach-laser-system/2486382/Wingderm announced that its Lasermach laser system has received expanded clearance from the US Food and Drug Administration (FDA), enabling use across all 3 wavelengths—755 nm, 808 nm, and 1064 nm. The update includes clearance for a mixed-wavelength handpiece combining all 3 wavelengths, as well
- FDA Approves Restylane Contour for Temple Hollowing Correctionhttps://modernaesthetics.com/news/fda-approves-restylane-contour-for-temple-hollowing-correction/2486354/Galderma announced that the U.S. Food and Drug Administration (FDA) has approved Restylane® Contour™ for the correction of temple hollowing in patients aged 21 years and older, expanding its indications beyond cheek augmentation and midface contour deficiencies. The approval enables clinicians to
- New Hydrobiome Serum Targets Skin Barrier and Microbiome Balancehttps://modernaesthetics.com/news/new-hydrobiome-serum-targets-skin-barrier-and-microbiome-balance/2486308/Epicutis has announced the launch of Hydrobiome Serum, a new addition to its clinical skincare portfolio developed in partnership with Signum Biosciences. The formulation is designed for patients with blemish-prone or congested skin and emphasizes microbiome balance and barrier support rather tha
- New Skin Quality Index Aims to Align Patient–Provider Communication in Aestheticshttps://modernaesthetics.com/news/new-skin-quality-index-aims-to-align-patientprovider-communication-in-aesthetics/2486112/Allergan Aesthetics, an AbbVie company, announced the launch of the Skin Quality Index (SQI), a new framework designed to standardize how patients and health care providers discuss skin quality during aesthetic consultations. The initiative is supported by global research published in Dermato
- LaserAway Introduces Three New Services Across Its Clinic Networkhttps://modernaesthetics.com/news/laseraway-introduces-three-new-services-across-its-clinic-network/2486088/LaserAway announced the launch of 3 new services across its clinic network: the Salmon DNA Facial, XTherma, and an expanded portfolio of LaserAway Wellness Injections. The company said the additions reflect continued investment in science-backed treatments and its medical-first approach to expand
- Global Study Finds Post-COVID Surge in Cosmetic Procedures, Led by Nonsurgical Fat Reductionhttps://modernaesthetics.com/news/global-study-finds-post-covid-surge-in-cosmetic-procedures-led-by-nonsurgical-fat-reduction/2485998/A global analysis of aesthetic procedure trends suggests the COVID-19 pandemic produced both immediate and sustained shifts in cosmetic procedure demand, with notable regional differences in surgical and nonsurgical treatments.
- Study Reports Improved Tolerability with Biomimetic Exosome Retinalhttps://modernaesthetics.com/news/study-reports-improved-tolerability-with-biomimetic-exosome-retinal/2485852/A novel retinal formulation delivered via a biomimetic exosome platform was associated with significant clinical improvements in photodamaged skin without reported irritation, according to a 12-week study published in the Journal of Cosmetic Dermatology. In the single-center study